Pepromene Bio
Advertisement
PeproMene Bio Inc., based in Irvine, California, is a clinical-stage biotech company dedicated to developing innovative immune therapies aimed at improving the lives of patients with cancer and immune disorders. Their BAFF-R CAR-T therapy program targets the B-cell Activating Factor Receptor, a promising approach discovered by Dr. Larry Kwak's team, with applications in treating various B-cell malignancies and autoimmune diseases.
With a strong focus on advancing novel therapies, PeproMene Bio is pioneering research that has shown great potential in overcoming challenges such as tumor relapse. The company actively seeks partnerships and investments that align with its mission to address significant unmet medical needs in the field of oncology and immunotherapy.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2026. All rights reserved.
Advertisement


